[stock_market_widget type=”ticker-quotes” template=”basic” color=”#5679FF” assets=”MSFT,AAPL,NFLX,GOOG,TSLA,NFLX,AMZN” animation=”true” display_currency_symbol=”true” api=”yf” speed=”50″ direction=”left” pause=”true”]
Eagle Bancorp Montana, Inc. (EBMT)
Eagle Bancorp Montana, Inc. (Nasdaq:EBMT) is the bank holding company for Opportunity Bank of Montana that provides various...
Franklin Financial Services Corporation (FRAF)
Franklin Financial Services Corporation (Nasdaq:FRAF) is a notable bank...
Financial Institutions, Inc. (FISI)
Financial Institutions, Inc. (Nasdaq:FISI) is a holding company for Five...
Citizens Community Bancorp, Inc. (CZWI)
Citizens Community Bancorp, Inc. (Nasdaq:CZWI) operates as a bank holding...
nCino (NASDAQ: NCNO) to Acquire FullCircl
nCino (NASDAQ: NCNO) to Acquire FullCircl nCino, Inc. (NCNO), the leading provider of intelligent, best-in-class banking...
Small Cap Big Business Trailer
[stock_market_widget type=”ticker-news” template=”background” color=”#002C66″ feed=”https://cointelegraph.com/rss” skip=”0″ limit=”20″ animation=”true” api=”news” speed=”150″ direction=”left” pause=”true”]
Founder Group Limited (NASDAQ: FGL) Shows Revenue Growth and Strategic Focus in Renewable Energy
Founder Group Limited (NASDAQ: FGL) Shows Revenue Growth and Strategic Focus in Renewable Energy Listed on NASDAQ in October 2024, Founder Group Limited (FGL) is making significant strides in the renewable energy and EPCC (Engineering, Procurement, Construction, and...
US election race tied 48%-48% between Trump and Harris, NYT poll shows
US election race tied 48%-48% between Trump and Harris, NYT poll shows The ongoing presidential race between Donald Trump and Kamala Harris remains extremely tight, a new poll from The New York Times and Siena College shows, with each candidate holding 48 percent of...
Lyell Immunopharma (Nasdaq: LYEL) to Acquire ImmPACT Bio, prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies
Lyell Immunopharma (Nasdaq: LYEL) to Acquire ImmPACT Bio, prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies Lyell Immunopharma, Inc. (Nasdaq: LYEL) announced today that it has entered into a definitive agreement to acquire ImmPACT Bio USA...
[stock_market_widget type=”accordion” template=”chart2″ color=”#002C66″ assets=”MSFT,AAPL,NFLX,^DJI,^GSPC,TSLA,META,QBIO” start_expanded=”false” display_currency_symbol=”true” api=”yf” chart_range=”1mo” chart_interval=”1d”]
sponsored advertisement
